Transforming function of the HOX11/TCL3 homeobox gene.
暂无分享,去创建一个
N. Zhang | T. Hawley | R. Hawley | M. Lu | M. Reis | A. Fong | N. Zhang | Robert G. Hawley | Marciano D. Reis | Nan Zhang | Ming Lu
[1] A. Ho,et al. Three distinct domains in the HOX-11 homeobox oncoprotein are required for optimal transactivation. , 1996, Oncogene.
[2] T. Reynolds,et al. A novel murine retrovirus identified during testing for helper virus in human gene transfer trials , 1996, Journal of virology.
[3] Takuro Nakamura,et al. Cooperative activation of Hoxa and Pbx1-related genes in murine myeloid leukaemias , 1996, Nature Genetics.
[4] U. Kees,et al. HOX11 expression in pediatric acute lymphoblastic leukemia is associated with T-cell phenotype. , 1995, Oncogene.
[5] T. Hawley,et al. Hematopoietic transforming potential of activated ras in chimeric mice. , 1995, Oncogene.
[6] I. Rambaldi,et al. Cooperative interactions between HOX and PBX proteins mediated by a conserved peptide motif , 1995, Molecular and cellular biology.
[7] Q. Lu,et al. Both Pbx1 and E2A-Pbx1 bind the DNA motif ATCAATCAA cooperatively with the products of multiple murine Hox genes, some of which are themselves oncogenes , 1995, Molecular and cellular biology.
[8] M. Cleary,et al. Pbx proteins display hexapeptide-dependent cooperative DNA binding with a subset of Hox proteins. , 1995, Genes & development.
[9] T. Rabbitts,et al. Chromosomal translocations in human cancer , 1994, Nature.
[10] M. Kamps,et al. Oncoprotein E2A-Pbx1 immortalizes a myeloid progenitor in primary marrow cultures without abrogating its factor-dependence. , 1994, Oncogene.
[11] J. Lust,et al. Tyrosine phosphorylation of JAK-TYK kinases in malignant plasma cell lines growth-stimulated by interleukins 6 and 11. , 1994, Biochemical and biophysical research communications.
[12] Tom Maniatis,et al. Transcriptional activation: A complex puzzle with few easy pieces , 1994, Cell.
[13] T. Hawley,et al. The HOX11 homeobox-containing gene of human leukemia immortalizes murine hematopoietic precursors. , 1994, Oncogene.
[14] E. Freireich,et al. Joining of recombination signals on the der 14q- chromosome in T-cell acute leukemia with t(10;14) chromosome translocation. , 1994, Cancer research.
[15] A. Perkins,et al. Conditional immortalization of mouse myelomonocytic, megakaryocytic and mast cell progenitors by the Hox‐2.4 homeobox gene. , 1993, The EMBO journal.
[16] D. Baltimore,et al. E2A-Pbx1, the t(1;19) translocation protein of human pre-B-cell acute lymphocytic leukemia, causes acute myeloid leukemia in mice , 1993, Molecular and cellular biology.
[17] A. Zlotnik,et al. Phenotypic and functional characterization of c-kit expression during intrathymic T cell development. , 1992, Journal of immunology.
[18] T. Hawley,et al. Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus , 1992, The Journal of experimental medicine.
[19] W. Shen,et al. DMSO improves PCR amplification of DNA with complex secondary structure , 1992 .
[20] I. Weissman,et al. Lymphocyte development from stem cells. , 1992, Annual review of immunology.
[21] S. Korsmeyer,et al. Chromosomal translocations in lymphoid malignancies reveal novel proto-oncogenes. , 1992, Annual review of immunology.
[22] S. Kamel‐Reid,et al. A novel human homeobox gene lies at the chromosome 10 breakpoint in lymphoid neoplasias with chromosomal translocation t(10;14) , 1991 .
[23] M. Cleary,et al. PBX2 and PBX3, new homeobox genes with extensive homology to the human proto-oncogene PBX1 , 1991, Molecular and cellular biology.
[24] M. Lu,et al. The tcl‐3 proto‐oncogene altered by chromosomal translocation in T‐cell leukemia codes for a homeobox protein. , 1991, The EMBO journal.
[25] G. Schieven,et al. Engagement of interleukin-7 receptor stimulates tyrosine phosphorylation, phosphoinositide turnover, and clonal proliferation of human T-lineage acute lymphoblastic leukemia cells. , 1991, Blood.
[26] C. Fox,et al. Cloning of a human homeobox gene that resembles a diverged Drosophila homeobox gene and is expressed in activated lymphocytes. , 1991, The New biologist.
[27] A. Strasser,et al. Novel murine homeo box gene on chromosome 1 expressed in specific hematopoietic lineages and during embryogenesis. , 1991, Genes & development.
[28] T. Hawley,et al. Leukocytosis in mice following long-term reconstitution with genetically-modified bone marrow cells constitutively expressing interleukin 1 alpha or interleukin 6. , 1991, Leukemia research.
[29] T. Hawley,et al. Establishment of a novel factor-dependent myeloid cell line from primary cultures of mouse bone marrow. , 1991, Cytokine.
[30] E. Leonard,et al. A multiwell cell settling and adherence chamber for morphology and differential counting. , 1990, BioTechniques.
[31] T. Agthoven,et al. Interleukin-7 is a growth factor of precursor B and T acute lymphoblastic leukemia. , 1990, Blood.
[32] R. Boyd,et al. The effects of interleukin 2 on early and late thymocyte differentiation in foetal thymus organ culture. , 1990, International immunology.
[33] J. Garcia,et al. Expression of human adenosine deaminase in mice after transplantation of genetically-modified bone marrow. , 1990, Blood.
[34] David Baltimore,et al. A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B all , 1990, Cell.
[35] Michael L. Cleary,et al. Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor , 1990, Cell.
[36] M. Egerton,et al. A murine early thymocyte developmental sequence is marked by transient expression of the interleukin 2 receptor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[37] J. M. Adams,et al. Expression of multiple homeobox genes within diverse mammalian haemopoietic lineages. , 1988, The EMBO journal.
[38] F. Dumont,et al. N-terminal and cDNA characterization of murine lymphocyte antigen Ly-6C.2. , 1988, Journal of immunology.
[39] H. Karasuyama,et al. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors , 1988, European journal of immunology.
[40] H. Pircher,et al. T cell receptor variable gene usage in a specific cytotoxic T cell response. Primary structure of the antigen-MHC receptor of four hapten- specific cytotoxic T cell clones , 1987, The Journal of experimental medicine.
[41] M. McBurney,et al. Cloning and expression of the mouse pgk-1 gene and the nucleotide sequence of its promoter. , 1987, Gene.
[42] A. Tartakoff,et al. Hydrophilic anchor-deficient Thy-1 is secreted by a class E mutant T lymphoma , 1986, Cell.
[43] C. Yanisch-Perron,et al. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. , 1985, Gene.
[44] R. Hawley,et al. Transposition of two different intracisternal A particle elements into an immunoglobulin kappa-chain gene , 1984, Molecular and cellular biology.
[45] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[46] C. Taylor,et al. Experimental models of lymphoproliferative disease. The mouse as a model for human non-Hodgkin's lymphomas and related leukemias. , 1983, The American journal of pathology.
[47] J. Ihle,et al. Biologic properties of homogeneous interleukin 3. I. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, p cell-stimulating factor activity, colony-stimulating factor activity, and histamine-producing cell-stimulating factor activity. , 1983, Journal of immunology.
[48] B. Reiss,et al. Nucleotide sequence and exact localization of the neomycin phosphotransferase gene from transposon Tn5. , 1982, Gene.
[49] C. Gahmberg,et al. Induction of erythroid differentiation in the human leukaemia cell line K562 , 1979, Nature.